Search

everythinglearnresearchcommunity

for

Search:↓

Certain genes are linked to the risk of developing Alopecia Areata.

A genetic marker linked to a type of hair loss was found in most patients studied.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

The review says skin conditions with sterile pustules need more research for better treatments.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Further research is needed to improve hair regeneration using stem cells and nanomaterials.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

The 60-second timed hair count is a reliable and simple way to measure hair shedding at home, showing older women tend to shed more hair than younger women.